Reporting
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
Learn MoreReporting
A proof-of-concept study to assess the effect of recombinant human growth hormone on the size of the replication-competent viral reservoir in HIV-infected individuals on suppressive ART
Learn MoreReporting
Impact of HIV infection and antiretroviral therapy on mucosal and systemic memory CD4 T cells
Learn MoreResults
Use of valproic acid to purge HIV from resting CD4+ memory cells: Trial results
Learn MoreEnrolling
Vedolizumab treatment in antiretroviral drug treated chronic HIV infection, followed by analytical treatment interruption (HIV-ART-vedolizumab-ATI)
Learn MoreReporting
The effect of metformin on HIV reservoir size in non-diabetic ART-treated patients
Learn MoreTerminated
A pilot randomized, open label study to evaluate the effect of a therapeutic HIV vaccine consisting of PENNVAX®-GP (gag, pol, env) and INO-9012 DNA vaccine delivered via electroporation on reducing HIV viral reservoirs in infected individuals, who initiated therapy during the acute/early phase of infection
Learn MoreResults
Effects of HLA allele frequencies on HIV disease progression and viral load among newly diagnosed HIV infected individuals in Manitoba: Trial Results
Learn More